Related by context. All words. (Click for frequent words.) 70 Palifosfamide delivers 69 5 FU leucovorin 67 gemcitabine Gemzar 67 adriamycin 67 erlotinib Tarceva ® 66 dasatinib Sprycel 66 alkylating agent 66 oxaliplatin Eloxatin 66 alkylating 66 idarubicin 66 CYT# potent vascular disrupting 65 pharmacologically active isomer 65 PEGylated anti 65 refractory chronic lymphocytic 65 TNF Tumor Necrosis Factor 65 imatinib Gleevec ® 65 vinca alkaloid 65 oral prodrug 65 gemcitabine chemotherapy 65 pegylated 64 Pemetrexed 64 Interferon alpha 64 docetaxel Taxotere R 64 systemic anaplastic large 64 paclitaxel Taxol ® 64 iniparib 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 cisplatin gemcitabine 64 additionally contraindicated 64 Epratuzumab 64 Camptosar ® 64 sorafenib Nexavar 63 5 fluorouracil 63 PEGylated Fab fragment 63 myelosuppression 63 docetaxel Taxotere ® 63 nucleoside analogues 63 bevacizumab Avastin ® 63 paclitaxel Taxol 63 5 Fluorouracil 63 docetaxel chemotherapy 63 daunorubicin 63 nucleoside reverse transcriptase inhibitor 63 Taxol paclitaxel 63 Xanafide 63 MAGE A3 ASCI 63 myelofibrosis polycythemia vera 63 pertuzumab 63 liposomal formulation 63 standard chemotherapy regimens 63 cyclophosphamide Cytoxan 63 cyclophosphamide methotrexate 63 metastatic malignant 63 imatinib resistant 63 anticancer therapy 63 DOXIL 63 targeted radiotherapeutic 63 dasatinib Sprycel ® 63 erlotinib Tarceva 63 FOLFOX chemotherapy 63 Voreloxin 63 ara C 63 cidofovir 63 anti tumor necrosis 63 Orally administered 63 gemcitabine carboplatin 62 Irinotecan 62 Leukine ® 62 alpha interferons 62 pan HDAC inhibitor 62 Paraplatin ® 62 Dasatinib 62 thalidomide Thalomid 62 SSc 62 cetuximab Erbitux ® 62 plus prednisone prednisolone 62 Platinol ® 62 Gemzar ® 62 FUSILEV enhances 62 Lenalidomide 62 trabectedin 62 sorafenib tablets 62 Trastuzumab 62 MyVax R 62 bone marrow suppression 62 evaluating tivozanib 62 interferon alfa 62 target enzyme thymidylate 62 interleukin IL -# 62 triple nucleoside regimen 62 trastuzumab Herceptin R 62 AEG# 62 3TC lamivudine Epivir 62 HER2 overexpression 62 IMiDs ® 62 AVASTIN 62 Pegasys ® 62 Aflibercept 62 vinca alkaloids 62 EGFR inhibitors 62 Platinol ® cisplatin 62 Taxotere ® 62 hA# 61 lapatinib Tykerb 61 pegylated interferons 61 LHRH antagonists 61 TAXOTERE ® 61 pharmacokinetic interactions 61 temozolomide Temodar 61 Seliciclib 61 docetaxel Taxotere 61 epithelial tumors 61 luteinizing hormone releasing 61 nucleoside analog 61 novel topoisomerase 61 FOLFOX6 61 antimetabolite 61 hypereosinophilic syndrome 61 androgen independent 61 Vidaza azacitidine 61 epirubicin cisplatin 61 fluorouracil 61 doxorubicin Adriamycin 61 cell lymphoma CTCL 61 5 fluorouracil leucovorin 61 tamoxifen Nolvadex ® 61 standard chemotherapy regimen 61 metastatic GIST 61 Doxorubicin 61 relapsed SCLC 61 gefitinib Iressa 61 mapatumumab 61 pyrazinamide 61 FOLFIRI 61 trastuzumab Herceptin ® 61 gastrointestinal stromal tumors GIST 61 receptor tyrosine kinase inhibitor 61 nevirapine Viramune 61 Paraplatin ® carboplatin 61 cetuximab Erbitux R 61 sargramostim 61 developing Bicifadine serotonin 61 DFMO 61 gemcitabine Gemzar ® 61 amprenavir 61 TNFalpha 61 Gleevec resistant 61 interferon alfa 2b 61 formoterol fumarate 61 recurrent glioblastoma multiforme 61 estramustine 61 complement inhibitor eculizumab 61 EGFR TKI 61 oblimersen 61 busulfan 61 mTOR mammalian target 61 Vidaza ® 61 ZOLINZA 61 FASLODEX 61 Fludarabine 61 imatinib Gleevec 61 CHOP chemotherapy 61 factor HGF 61 generation purine nucleoside 61 liposomal doxorubicin 61 Phase #b/#a clinical 61 leucovorin 61 cediranib 61 potentially hepatotoxic 61 bevacizumab Avastin R 61 systemic corticosteroid 61 pegylated liposomal doxorubicin 61 cytarabine daunorubicin 61 INCB# [001] 61 MGd 61 ribavirin RBV 61 ZEVALIN therapeutic regimen 61 lenalidomide dexamethasone 61 D aspartate NMDA receptor 61 capecitabine Xeloda 61 CYP#A# CYP#D# 60 cyclophosphamide doxorubicin vincristine 60 benign prostatic hypertrophy BPH 60 bortezomib Velcade R 60 brand ciclesonide HFA 60 gastrointestinal stromal tumor GIST 60 intravesical infusion therapy 60 bleomycin 60 Gleevec imatinib mesylate 60 YONDELIS 60 anthracyclines taxanes 60 Cisplatin 60 efavirenz Sustiva 60 irinotecan chemotherapy 60 severe neutropenia 60 taxane chemotherapy 60 Peg IFN 60 Tumor Necrosis Factor 60 metastatic colorectal 60 Taxol ® 60 tanespimycin 60 doxorubicin HCl liposome injection 60 Methylnaltrexone 60 Fludara 60 Peginterferon alfa 2b 60 antibody MAb 60 systemic fungal infections 60 ADP receptor antagonist 60 Trabectedin 60 Camptosar ® irinotecan 60 hyperplasia BPH 60 PSMA ADC 60 bevacizumab Avastin 60 uric acid lowering 60 chemically modified siRNA 60 EndoTAGTM 1 60 leukemia AML 60 HuMax EGFr 60 virus HCV protease inhibitor 60 fluoropyrimidine 60 BCG refractory carcinoma 60 autoantibody levels 60 chronic eosinophilic leukemia 60 ® lenalidomide 60 Fludara ® 60 Alkeran 60 tenofovir emtricitabine 60 Anthracyclines 60 zidovudine AZT 60 IFN alpha 60 fulvestrant 60 esophageal candidiasis 60 evaluating picoplatin 60 refractory cutaneous T 60 cilengitide 60 calcineurin inhibitors 60 basal cell carcinoma BCC 60 granulocyte colony stimulating 60 Gleevec imatinib 60 Elvitegravir 60 Bevacizumab 60 chemotherapeutic regimen 60 SPRYCEL ® 60 Interferon beta 60 chemotherapeutic agent 60 GW# [003] 60 invasive candidiasis 60 Ribavirin causes 60 mitoxantrone plus 60 nilotinib Tasigna ® 60 pegylated interferon alfa 2a 60 ritonavir boosted 60 abacavir lamivudine 60 visilizumab 60 EGFr 60 anti angiogenic agent 60 diarrhea predominant irritable 60 TAXOTERE R 60 dacarbazine 59 interferon gamma 1b 59 laropiprant 59 Helicobacter pylori H. pylori 59 Cremophor 59 Navelbine 59 IgG1 antibody 59 interferon IFN 59 selective modulator 59 posaconazole 59 IAP inhibitor 59 protease inhibitor PI 59 delayed CINV 59 panitumumab Vectibix 59 denileukin diftitox 59 EGFR tyrosine kinase inhibitors 59 chemotherapy cisplatin 59 Xeloda ® 59 Taxotere chemotherapy 59 R Saizen R 59 mTOR inhibitor 59 refractory AML 59 Taxotere docetaxel 59 cabazitaxel 59 IMiDs R 59 T#I [002] 59 Cytoxan 59 protein tyrosine phosphatase 1B 59 CANCIDAS 59 Ad5FGF 4 59 Hsp# Inhibitor 59 Zolinza 59 antiinflammatory 59 bicalutamide 59 Pegylated Interferon 59 Cloretazine 59 thymidylate synthase 59 ADAMTS# 59 anthracycline taxane 59 BRAF kinase 59 Mg Usa 59 NR2B selective 59 VEGF inhibitors 59 trans retinoic acid 59 alfa 2a 59 Zorbtive TM 59 metastatic castration resistant 59 solar keratoses 59 antiemetics 59 L asparaginase 59 systemic antifungal 59 K ras mutations 59 hyperphenylalaninemia HPA due 59 plus gemcitabine 59 relapsed ovarian cancer 59 molecularly targeted 59 isoproterenol 59 tumor xenograft models 59 IMiDs ® compound 59 Combination therapy 59 indinavir 59 depsipeptide 59 Nilotinib 59 PKC# 59 PNP inhibitor 59 monoclonal antibody IgG1 Mab 59 GRN#L 59 vorinostat 59 Vidofludimus 59 ixabepilone 59 Apaziquone 59 small molecule Hedgehog 59 Velcade bortezomib 59 mRCC 59 Serostim ® 59 Elotuzumab 59 HuLuc# 59 forodesine 59 leukemia CLL 59 Etoposide 59 refractory multiple myeloma 59 eflornithine 59 pegylated interferon alpha 59 chronic lymphocytic leukemia CLL 59 huC# DM4 59 chemoresistance 59 mycophenolate mofetil 59 paclitaxel cisplatin 59 Pegloticase 59 endocrine therapies 59 Inhalation Solution 59 intravenous bisphosphonates 59 proteasome inhibitor bortezomib 59 lenalidomide Revlimid R 59 unresectable tumors 59 refractory NSCLC 59 vWF 59 investigational oral inhibitor 59 Oral corticosteroids 59 PREZISTA rtv 59 Mitoxantrone 59 gastrointestinal stromal tumor 59 basiliximab 59 sorafenib Nexavar R 59 proteasome inhibitor 59 Myelofibrosis 59 Meets Primary Endpoint 59 Epirubicin 59 HGS# 59 familial amyloidotic polyneuropathy FAP 59 Lenocta 59 metaglidasen 59 CDDO Im 59 metformin sulfonylurea 59 Akt activation 59 indolent NHL 59 metastatic gastric 59 mertansine 59 Mg Uk 59 voriconazole 59 tenofovir Viread 59 decitabine 59 overlapping toxicities 59 tiotropium bromide 59 sorafenib Nexavar ® 59 adalimumab Humira 59 macrophage colony stimulating 59 refractory chronic myeloid 59 HGS ETR1 59 q8h 59 Bleomycin 59 lipid elevations 59 pathophysiological effects 59 cisplatin chemotherapy 59 polyneuropathy HIV DSP 59 subependymal giant cell 59 nephrotoxicity 59 tinidazole 59 relapsed multiple myeloma 59 Aliskiren 59 Bezielle 59 CIMZIA ™ 59 metastatic neuroendocrine tumors 58 accumulate preferentially 58 glioblastoma multiforme GBM 58 Alemtuzumab 58 Doxil ® 58 azacytidine 58 cutaneous T 58 Platinol 58 Abatacept 58 Factor Receptor 58 trans retinoic acid ATRA 58 Bortezomib 58 MCyR 58 IMA# 58 sulfasalazine 58 xanthine oxidase inhibitor 58 microtubule inhibitor 58 non nucleoside inhibitor 58 Tarceva TM 58 Hodgkin lymphoma NHL 58 liposome encapsulated 58 Tasimelteon 58 trastuzumab Herceptin 58 temsirolimus 58 recurrent glioblastoma 58 steroid dexamethasone 58 essential thrombocythemia 58 pomalidomide 58 Vincristine 58 vinorelbine 58 Pertuzumab 58 cytotoxic chemotherapy 58 Decitabine 58 dasatinib 58 carboplatin chemotherapy 58 NAGS deficiency 58 octreotide 58 Cytarabine 58 HCV NS5B polymerase 58 receptor inhibitor 58 4mg/kg 58 Vandetanib 58 colorectal liver metastases 58 metastatic malignant melanoma 58 refractory gout 58 carboplatin paclitaxel 58 azoles 58 cetuximab Erbitux 58 LymphoStat B belimumab 58 long acting bronchodilator 58 5-FU/LV 58 folinic acid 58 Glioblastoma multiforme GBM 58 Romiplostim 58 grade cervical intraepithelial 58 metastatic CRC 58 dose cytarabine 58 tyrosine kinase inhibitors TKIs 58 erlotinib Tarceva R 58 Hormone Refractory Prostate Cancer 58 myeloid 58 systemic lupus erythematosus SLE 58 chlorambucil 58 Vaprisol 58 nucleoside reverse transcriptase inhibitors 58 NRTI 58 induce orthostatic hypotension 58 infusional 5-FU/LV 58 Epivir 58 pemetrexed Alimta 58 systemic ALCL 58 potent CYP#A# inhibitors 58 acute GvHD 58 mycosis fungoides 58 zalutumumab 58 Naive Patients 58 meropenem 58 Dapagliflozin 58 Cyclosporine 58 Telintra 58 Carboplatin 58 sodium glucose cotransporter 58 CYP #A# 58 investigational monoclonal antibody 58 immune modulator 58 imatinib mesylate 58 #mg/#mg 58 Fluorouracil 58 Halaven 58 MET VEGFR2 58 sunitinib malate 58 Ophena TM 58 colorectal carcinoma 58 alpha folate receptor 58 mu opioid receptor antagonist 58 androgen deprivation 58 Toxicities 58 opioid induced bowel dysfunction 58 autoantibody positive 58 novel VDA molecule 58 FOLFOX4 58 HER2 receptor 58 leukemia ALL 58 Golimumab 58 ALA PDT 58 kidney urologic 58 Pafuramidine 58 Atripla combines 58 Refractory Hodgkin Lymphoma 58 prostate cancer HRPC 58 radiochemotherapy 58 relapsed leukemia 58 angiogenesis inhibitor 58 mitochondrial toxicity 58 papillary renal cell carcinoma 58 mGluR5 NAM 58 bortezomib Velcade 58 Erlotinib 58 fallopian tube cancers 58 Natalizumab 58 Omacetaxine 58 TNF alpha antagonist 58 corticosteroid dexamethasone 58 recurrent genital herpes 58 cutaneous T cell 58 Virulizin ® 58 clodronate 58 Noxafil 58 thymalfasin 58 renal toxicity 58 anti androgen 58 granulocyte macrophage colony stimulating 58 Alocrest 58 relapsing remitting MS RRMS 58 Cutaneous T 58 complete cytogenetic response 58 velafermin 58 Tamibarotene 58 2 methoxyestradiol 58 anti EGFR antibody 58 cytoreduction 58 evaluating Xcytrin 58 diabetic gastroparesis 58 relapsed MM 58 atypical hemolytic uremic syndrome 58 endometrial hyperplasia 58 ethambutol 58 TLK# 58 flutamide 58 hematologic toxicity 58 paclitaxel carboplatin 58 immunomodulating 58 PRT# 58 cytoprotective 58 BRAF inhibitor 58 Chronic lymphocytic leukemia 58 chemotherapeutic drug 58 idiopathic pulmonary fibrosis IPF 58 taxane refractory 58 cisplatin carboplatin 58 cinacalcet 58 teriflunomide 58 INTEGRILIN R 58 NS5B polymerase 58 systemic immunosuppressive drugs 58 pan histone deacetylase 58 Sudhir Agrawal D.Phil 58 ABVD 58 Temsirolimus 58 Xelox 58 octreotide LAR 58 pegfilgrastim 58 mitomycin 58 refractory ovarian cancer 58 epirubicin 58 antimetabolites 58 telaprevir dosed 58 signal transduction inhibitors 58 tipranavir 58 colon carcinoma 58 Complicated Skin 58 rosuvastatin #mg 58 proteasome inhibitors 58 Desmopressin 58 CYP#A# substrate 58 stavudine 58 BCG refractory 58 CBLC# 57 low dose cytarabine 57 constipation OIC 57 HMG CoA reductase inhibitors 57 T#I mutant 57 LHRH agonist 57 doxorubicin 57 delivers fluocinolone acetonide FA 57 Pioglitazone 57 atrasentan 57 Peginterferon 57 cisplatin resistant 57 ELOXATIN 57 5 HT6 receptor 57 chemotherapeutic regimens 57 LHRH analogues 57 Gliadel Wafer 57 relapsed refractory multiple myeloma 57 chemotherapy FOLFOX 57 Neulasta ® 57 ACTEMRA TM 57 oral ridaforolimus 57 rifampicin 57 beclomethasone dipropionate 57 efalizumab 57 Mitomycin C 57 tigecycline 57 Myelodysplastic Syndrome MDS 57 antiandrogen 57 nicardipine 57 corticosteroid therapy 57 imatinib resistance 57 pegylated interferon alfa 57 5FU 57 acute promyelocytic leukemia 57 factor VIIa 57 factor G CSF 57 hypoxia inducible factor 57 hormone LHRH antagonist 57 lumiliximab 57 headache nasopharyngitis 57 relapsing multiple sclerosis 57 synthetic retinoid 57 leukemia CML 57 EGF receptor 57 bexarotene 57 Vascular endothelial growth 57 Gemzar gemcitabine 57 sarcomatoid 57 tegafur 57 Cyclophosphamide 57 CYC# 57 Pharmacokinetics PK 57 Kepivance 57 Degarelix 57 PD LID 57 stem cell pluripotency 57 Adalimumab 57 effector function 57 flavopiridol 57 myelosuppressive 57 raltegravir 57 herpes zoster shingles 57 cytostatic 57 Moxifloxacin 57 MYLOTARG 57 phase IIb trial 57 sapropterin dihydrochloride Tablets 57 anterior uveitis 57 camptothecin 57 HER1 57 Amrubicin 57 NRTIs 57 weekly subcutaneous injections 57 5 HT4 57 pseudobulbar affect PBA 57 baminercept 57 Gefitinib 57 vWD 57 tyrosine kinase inhibitor 57 ANCA associated 57 active metabolite 57 PREZISTA r 57 PegIFN RBV 57 DOXIL ® 57 anti leukemic 57 beta lactam antibiotic 57 varicella zoster virus 57 reslizumab 57 pyrimethamine 57 Hycamtin 57 ipratropium bromide 57 HER2 positive metastatic breast 57 APTIVUS 57 isoenzyme 57 Rituxan rituximab 57 Campath alemtuzumab 57 Fulvestrant 57 SUPPRELIN R LA 57 cytogenetic responses 57 C1 INH deficiency 57 Anthracycline 57 fallopian tube carcinoma 57 beta 1a 57 Annamycin 57 colony stimulating factor 57 infusional 57 Folfox 57 dexrazoxane 57 canakinumab 57 anaplastic 57 Capecitabine 57 gemcitabine cisplatin 57 AEGR 57 chemoradiation therapy 57 aspirin clopidogrel 57 anthracycline chemotherapy 57 platelet inhibitor 57 aprepitant 57 angiogenesis inhibition 57 platinum refractory 57 comparator arm 57 Copegus ribavirin 57 cardiotoxic 57 Leukine 57 low dose ritonavir 57 IRX 2 57 factor Xa 57 radiation chemoradiation 57 immunosuppressant 57 multiple myeloma MM 57 Candida infection 57 Eltrombopag 57 transplantation HCT 57 Herceptin trastuzumab 57 vinflunine 57 carcinoma mCRC 57 alefacept 57 peginterferon alfa 2b 57 JAK inhibitor 57 Atopic dermatitis 57 hormone LHRH 57 oral clodronate 57 BAY #-# 57 paclitaxel Taxol R 57 mTOR kinase 57 Carcinoid tumors 57 DU #b 57 XmAb# 57 VELCADE melphalan 57 immune modulating 57 risedronate Actonel 57 GRNOPC1 contains 57 Inhaled nitric oxide 57 Etanercept 57 Inhaled corticosteroids 57 γ secretase 57 immunostimulatory 57 recurrent NSCLC 57 erythropoietic 57 recurrent metastatic ovarian cancer 57 PDGF receptor 57 interferon alfa 2a 57 splenectomized 57 PegIntron 57 hepatocellular 57 OMP #R# 57 severe oral mucositis 57 Navelbine ® 57 lanreotide 57 orally bioavailable mimics 57 infliximab monotherapy 57 fibrotic disease 57 B7 H3 57 bone metastasis 57 SGPT 57 dexamethasone Decadron 57 piperacillin tazobactam 57 8mg/kg 57 advanced hepatocellular carcinoma 57 recombinant interferon 57 Genentech Rituxan 57 ursodeoxycholic acid 57 Parnate 57 HDACi 57 mesylate 57 TKI therapy 57 hypercalcemia 57 APTIVUS r 57 doxorubicin cyclophosphamide 57 Adjuvant chemotherapy 57 methotrexate MTX 57 pralatrexate injection folate analogue 57 paclitaxel poliglumex 57 gp# vaccine 57 Jevtana 57 follicular lymphoma FL 57 DMARDs 57 Coadministration 57 candesartan cilexetil 57 Aptivus ® 57 serum phosphate 57 Epstein Barr Virus EBV 57 achieved ACR# 57 bendamustine 57 gastric carcinoma 57 inhibitor RG# 57 interferon beta therapy 57 Maribavir 57 intradermal injection 57 idiopathic thrombocytopenic purpura ITP 57 castrate resistant prostate cancer 57 Kivexa 56 boosted protease inhibitor 56 Janus kinase 56 Gemcitabine 56 elotuzumab 56 psoriatic arthritis PsA 56 cysteamine bitartrate 56 Neutropenia 56 systemic lupus erythematosus 56 Known generically 56 TAXOL 56 Roche Xeloda 56 aripiprazole Abilify 56 caspofungin 56 histone deacetylase inhibitor 56 Chemophase 56 novel emulsion formulation 56 superficial bladder cancer 56 radiolabeled TM# 56 GPIIb IIIa 56 poly ADP ribose polymerase 56 BRAF mutations 56 gastrointestinal stromal tumors 56 Upregulation 56 Epidermal Growth Factor Receptor 56 TNF blocker therapy 56 Nebulized 56 cyclophosphamide 56 Ozarelix 56 ovarian carcinoma 56 microtubule targeting 56 Altera Nebulizer System 56 Intravenous CP 56 chemosensitivity 56 LHRH agonists 56 abnormal p# 56 pancreatic prostate 56 Hepatocellular Carcinoma HCC 56 cranial irradiation 56 myopathy rhabdomyolysis 56 Torisel 56 hydralazine 56 tyrosine kinase inhibitors 56 Pathway Inhibitor 56 hepatocyte growth 56 malignant pleural mesothelioma 56 underlying vasculopathy 56 ceftriaxone 56 Malignant Glioma 56 Temozolomide 56 acetonide FA 56 alvespimycin 56 amphotericin B 56 OncoVEX GM CSF 56 inhibit VEGF 56 aflibercept VEGF Trap 56 essential thrombocythemia ET 56 reversible inhibitor 56 thrombocytosis 56 PTP 1B 56 imipenem 56 CIPN 56 transgene expression 56 mediated apoptosis 56 TRPV1 agonist 56 Glucocorticoids 56 ribavirin therapy 56 chronic idiopathic thrombocytopenic purpura 56 PDGFR 56 mucosal healing 56 antitumor effect 56 anakinra 56 imatinib therapy 56 Neoadjuvant 56 DPP4 56 demethylating agent 56 esomeprazole Nexium 56 myeloproliferative disorders 56 EGFR expressing mCRC 56 nausea vomiting headache 56 neovascular diseases 56 TTF Therapy 56 calcineurin inhibitor 56 H2 blockers 56 Axitinib 56 antiestrogen 56 Platelet Derived Growth 56 ganetespib 56 anti angiogenic agents 56 mitoxantrone chemotherapy 56 glucagon receptor 56 vinblastine 56 atypical Hemolytic Uremic Syndrome 56 INSPIRE Trial Phase III 56 deletion 5q 56 hematologic disorders 56 CTLA 4 56 metastatic RCC 56 irbesartan 56 PAOD 56 non alcoholic steatohepatitis 56 biologic DMARD 56 locoregional 56 XELOX 56 antisense oligonucleotide 56 COX2 56 Imprime PGG 56 echinocandin 56 Doxil 56 QVAR ® 56 mTOR inhibitors 56 Imatinib 56 inhibit oxidative stress 56 octreotide acetate 56 Angiotensin converting enzyme 56 LRP5 56 PDE4 56 lamotrigine Lamictal 56 Known hypersensitivity 56 Cardiotoxicity 56 insulin sensitizing 56 Hycamtin ® 56 hypersensitivity reaction 56 Angiotensin II 56 mitogen activated protein kinase 56 azacitidine 56 Everolimus 56 itraconazole 56 taxol 56 tumor lysis syndrome 56 CYP#A# isoenzyme 56 Sanofi Aventis Taxotere 56 pyridostigmine 56 prescribed proton pump 56 pamidronate 56 neurologic progression 56 chemotherapy induced neutropenia 56 pentamidine 56 interferon beta 56 pharmacokinetic equivalence 56 acute promyelocytic leukemia APL 56 prostate cancer mCRPC 56 IIIa inhibitor 56 unresectable stage 56 hormone deprivation 56 melphalan prednisone 56 Relapsing remitting MS 56 peginterferon alfa 56 etanercept Enbrel 56 ErbB1 56 nilotinib 56 3 carbinol 56 activin 56 bezafibrate 56 selective agonist 56 Amplimexon 56 tocilizumab 56 R bisoprolol Euthyrox 56 postoperative chemotherapy 56 relapsed refractory 56 HBeAg positive patients 56 phase IIb clinical 56 olmesartan 56 fibrinolytic 56 palifosfamide 56 IMC A# 56 R metformin Concor 56 steroid prednisone 56 saline placebo 56 neutropenia dehydration dyspnea 56 Sym# 56 riociguat 56 gemifloxacin 56 TRANSDUR ® 56 vaginal candidiasis 56 Epstein Barr virus EBV 56 granisetron 56 dacetuzumab 56 endoxifen 56 diuretic hydrochlorothiazide 56 plus dexamethasone 56 Ceflatonin 56 oxcarbazepine 56 selective inverse agonist 56 squamous cell carcinoma SCC 56 Advair HFA 56 molecule epidermal 56 xenograft models 56 TELCYTA 56 regorafenib 56 apoptosis inducing 56 TGF ß 56 somatostatin analogue 56 Daclizumab 56 peritoneal carcinomatosis 56 raloxifene Evista 56 etoposide 56 bronchial hyperresponsiveness 56 fludarabine 56 alkylating agents